CIK: 0001232621 · Show all filings
Period: Q2 2014 (← Previous) (Next →)
Filing Date: Aug 14, 2014
Total Value ($000): $215,933 (65.7% shares, 34.3% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 4,919,625 | $60,610 | 28.1% | $12.54 | -4.7% | COM | 427746102 |
| — | PDL BIOPHARMA INC | 25,974,000 | $47,866 | 22.2% | $1.41 | — | NOTE 2.875% 2/15/15 | 69329YAE4 |
| — | SALIX PHARMACEUTICALS INC | 300,000 | $37,005 | 17.1% | $66.15 | — | COM | 795435106 |
| — | OPKO HEALTH INC | 14,000,000 | $18,739 | 8.7% | $1.04 | — | NOTE 3.0% 2/1/33 | 68375NAA1 |
| — | HORIZON PHARMA INC | 1,000,000 | $15,820 | 7.3% | $15.12 | — | COM | 44047T109 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 182,300 | $11,341 | 5.3% | $62.32 | -3.1% | COM | 09061G101 |
| — | LA JOLLA PHARMACEUTICAL CO | 881,907 | $8,096 | 3.7% | $9.20 | — | COM | 503459604 |
| — | MERRIMACK PHARMACEUTICALS INC | 5,500,000 | $7,490 | 3.5% | $1.36 | — | NOTE 4.5% 7/15/20 | 590328AA8 |
| — | MIRATI THERAPEUTICS INC | 288,432 | $5,769 | 2.7% | $15.15 | — | COM | 60468T105 |
| — | ENDOCYTE INC | 465,763 | $3,069 | 1.4% | $13.13 | — | COM | 29269A102 |
| — | DENDREON CORP | 55,548 | $128 | 0.1% | $4.12 | — | COM | 24823Q107 |
| — | AMBIT BIOSCIENCES CORP | 46 | $0 | 0.0% | — | — | COM | 02318X100 |